from 192 today
We cut our Revenue estimates for FY27 to account for delays in pipeline execution and maintain our BUY rating on the stock with a target price of Rs 240/share, implying an upside potential of 25% from the CMP.
Ratings and target prices as published by each firm. Each summary condenses that firm's stated view in its own note and is attributed to it; no report text is reproduced.
